Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors

The role of LAT1 in 18F-DOPA uptake in malignant gliomas

(2012) Ryan S. Youland et al.   JOURNAL OF NEURO-ONCOLOGY

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial

(2010) Stephanie E Combs et al.   BMC CANCER

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial

(2010) Stephanie E Combs et al.   BMC CANCER

Correlation of 6-18F-Fluoro-L-Dopa PET Uptake with Proliferation and Tumor Grade in Newly Diagnosed and Recurrent Gliomas

(2010) B. J. Fueger et al.   JOURNAL OF NUCLEAR MEDICINE

18F-FDOPA: A Multiple-Target Molecule

(2009) H. Minn et al.   JOURNAL OF NUCLEAR MEDICINE

Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2

(2008) Eva M. del Amo et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES